VRTX
Vertex Pharmaceuticals Incorporated
Healthcare
$433.54
as of May 21, 2026
Latest executive report
Week 2026-W29
· updated Jul 13, 2026
Sign in to add VRTX to your portfolio.
Sign inMarket cap
$109.25B
P/E (TTM)
25.2x
EPS (TTM)
$17.07
Dividend yield
—
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $7.57B | $2.34B | $2.41B | 88.1% | 36.7% | $9.09 |
| 2022 | $8.93B | $3.32B | $3.93B | 87.9% | 48.2% | $12.97 |
| 2023 | $9.87B | $3.62B | $3.28B | 87.2% | 38.8% | $14.05 |
| 2024 | $11.02B | $-535.60M | $-790.30M | 86.1% | -2.1% | $-2.08 |
| 2025 | $12.07B | $3.95B | $3.19B | 85.0% | 39.4% | $15.46 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $429.36 | $433.54 | 1.40M |
| May 20, 2026 | $434.31 | $430.44 | 1.78M |
| May 19, 2026 | $436.79 | $434.31 | 1.22M |
| May 18, 2026 | $435.42 | $436.58 | 1.45M |
| May 15, 2026 | $453.45 | $436.95 | 1.29M |
| May 14, 2026 | $453.64 | $450.41 | 1.09M |
| May 13, 2026 | $446.47 | $453.06 | 1.19M |
| May 12, 2026 | $439.92 | $448.29 | 1.40M |
| May 11, 2026 | $429.50 | $435.17 | 1.26M |
| May 08, 2026 | $422.37 | $429.82 | 953.35K |
| May 07, 2026 | $425.13 | $425.00 | 1.11M |
| May 06, 2026 | $422.67 | $427.65 | 1.20M |
| May 05, 2026 | $431.99 | $424.36 | 1.91M |
| May 04, 2026 | $423.75 | $429.85 | 1.42M |
| May 01, 2026 | $425.02 | $423.92 | 796.99K |
| Apr 30, 2026 | $423.66 | $427.38 | 1.12M |
| Apr 29, 2026 | $424.44 | $423.24 | 1.06M |
| Apr 28, 2026 | $431.25 | $430.14 | 808.54K |
| Apr 27, 2026 | $427.01 | $426.01 | 967.04K |
| Apr 24, 2026 | $431.89 | $430.29 | 1.13M |
| Apr 23, 2026 | $440.71 | $435.10 | 777.64K |
| Apr 22, 2026 | $437.38 | $437.67 | 734.33K |
| Apr 21, 2026 | $437.12 | $436.59 | 986.97K |
| Apr 20, 2026 | $444.01 | $439.18 | 789.46K |
Profitability & balance
- ROE (TTM)
- 23.9%
- Gross margin
- 86.3%
- Operating margin
- 39.0%
- Net margin
- 35.4%
- Debt / equity
- 0.10